Structure Therapeutics Inc.’s shares rose after more data on the company’s experimental weight-loss pill showed it’s shaping ...

Shares of Structure Therapeutics rallied 10% in premarket trade on Monday after the company said higher doses of its ...

GLP-1 drugs have quickly become a top tool in the fight against obesity, but there are quite a few choices.

Structure Therapeutics' oral obesity drug ​aleniglipron delivered up to 16.3% ‌weight loss when compared with a placebo after 44 weeks of ​treatment in a mid‑stage ​study, it said on Monday.

When she does decide to have a healthier lunch, Nicola prepares a low-carb salad with her husband Brooklyn.

A new report indicates that 70% of diet pill users experience side effects, including severe issues like suicidal thoughts. The study, involving 257 participants aged 19 to 64, found that 60% were not ...